Normalization of the sleep-wake pattern and melatonin and 6-sulphatoxy-melatonin levels after a therapeutic trial with melatonin in children with severe epilepsy

Journal of Pineal Research

Volumn 50, Issue 2, 2011, Pages 192-196

  Uberos, J ^a   Augustin Morales, M C ^a   Molina Carballo, A ^a   Florido, J ^a   Narbona, E ^a   Munoz Hoyos A ^a  

^a HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

Author keywords

clinical trial; epilepsy; melatonin; myoclonic epilepsy; sleep disorders

Indexed keywords

6 HYDROXYMELATONIN O SULFATE; MELATONIN; PLACEBO;

ACTIMETRY; ARTICLE; BRAIN ISCHEMIA; CHILD; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EXCRETION; EPILEPSY; EVENING DOSAGE; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; LENNOX GASTAUT SYNDROME; MYOCLONUS EPILEPSY; PRESCHOOL CHILD; SCHOOL CHILD; SLEEP PATTERN; SLEEP WAKING CYCLE; URINARY EXCRETION; WEST SYNDROME;

EPILEPSY; MELATONIN; PLACEBOS; SLEEP DISORDERS; TREATMENT OUTCOME;

EID: 79951590300     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2010.00828.x     Document Type: Article

References (35)

1. Chokroverty S, Sander HW, Avtukh V,. Did Dostoevsky have a primary sleep disorder besides epilepsy? Sleep Med 2007; 8: 281-283. (Pubitemid 46488863)
2. Kaleyias J, Cruz M, Goraya JS, et al. Spectrum of polysomnographic abnormalities in children with epilepsy. Pediatr Neurol 2008; 39: 170-176.
3. Mendez M, Radtke RA,. Interactions between sleep and epilepsy. J Clin Neurophysiol 2001; 18: 106-127. (Pubitemid 32549907)
4. De Weerd A, De Haas S, Otte A, et al. Subjective sleep disturbance in patients with partial epilepsy: a questionnaire-based study on prevalence and impact on quality of life. Epilepsia 2004; 45: 1397-1404. (Pubitemid 39470044)
5. Mitchell RB, Kelly J,. Outcome of adenotonsillectomy for obstructive sleep apnea in obese and normal-weight children. Otolaryngol Head Neck Surg 2007; 137: 43-48. (Pubitemid 46962164)
6. Bazil CW,. Epilepsy and sleep disturbance. Epilepsy Behav 2003; 4 (Suppl. 2): S39-S45. (Pubitemid 37407627)
7. Shouse MN, Da Silva AM, Sammaritano M,. Circadian rhythm, sleep, and epilepsy. J Clin Neurophysiol 1996; 13: 32-50. (Pubitemid 26005163)
8. Leu-Semenescu S, Arnulf I, Decaix C, et al. Sleep and rhythm consequences of a genetically induced loss of serotonin. Sleep 2010; 33: 307-314.
9. Wassmer E, Quinn E, Whitehouse W, Seri S,. Melatonin as a sleep inductor for electroencephalogram recordings in children. Clin Neurophysiol 2001; 112: 683-685. (Pubitemid 32245642)
10. Jan JE, Reiter RJ, Wasdell MB, Bax M,. The role of the thalamus in sleep, pineal melatonin production, and circadian rhythm sleep disorders. J Pineal Res 2009; 46: 1-7.
11. Peniston-Bird JF, Di WL, Street CA, Edwards R, Little JA, Silman RE,. An enzyme immunoassay for 6-sulphatoxy-melatonin in human urine. J Pineal Res 1996; 20: 51-56. (Pubitemid 126733174)
12. Nunes ML, Ferri R, Arzimanoglou A, Curzi L, Appel CC, Costa da CJ,. Sleep organization in children with partial refractory epilepsy. J Child Neurol 2003; 18: 763-766. (Pubitemid 38016568)
13. Jan JE, ODonnell ME,. Use of melatonin in the treatment of paediatric sleep disorders. J Pineal Res 1996; 21: 193-199. (Pubitemid 126733135)
14. Lapierre O, Dumont M,. Melatonin treatment of a non-24-hour sleep-wake cycle in a blind retarded child. Biol Psychiatry 1995; 38: 119-122.
15. Camfield P, Gordon K, Dooley J, Camfield C,. Melatonin appears ineffective in children with intellectual deficits and fragmented sleep: six ââN of 1ââ trials. J Child Neurol 1996; 11: 341-343. (Pubitemid 26234454)
16. Pillar G, Shahar E, Peled N, Ravid S, Lavie P, Etzioni A,. Melatonin improves sleep-wake patterns in psychomotor retarded children. Pediatr Neurol 2000; 23: 225-228.
17. Cavallo A, Good WV, Douglas RM, Succop P,. Dose response to melatonin treatment for disordered sleep rhythm in a blind child. Sleep Med 2002; 3: 159-161. (Pubitemid 34303115)
18. Uberos J, Romero J, Molina-Carballo A, Munoz-Hoyos A,. Melatonin and elimination of kynurenines in children with Downs syndrome. J Pediatr Endocrinol Metab 2010; 23: 277-282.
19. Jan MM,. Melatonin for the treatment of handicapped children with severe sleep disorders. Pediatr Neurol 2000; 23: 229-232.
20. Fauteck J, Schmidt H, Lerchl A, Kurlemann G, Wittkowski W,. Melatonin in epilepsy: first results of replacement therapy and first clinical results. Biol Signals Recept 1999; 2: 105-110. (Pubitemid 29132391)
21. Ortiz Camunez MA, Martin DA, Lluch Fernandez MD, Quesada Lucas MM, Gonzalez HJ,. [EEG with sleep deprivation in epileptic children]. An Esp Pediatr 1984; 21: 191-197.
22. Anton-Tay F,. Melatonin: effects on brain function. Adv Biochem Psychopharmacol 1974; 11: 315-324.
23. Molina-Carballo A, Munoz-Hoyos A, Rodriguez-Cabezas T, Acuna-Castroviejo D,. Day-night variations in melatonin secretion by the pineal gland during febrile and epileptic convulsions in children. Psychiatry Res 1994; 52: 273-283. (Pubitemid 24225425)
24. Molina-Carballo A, Acuna-Castroviejo D, Rodriguez-Cabezas T, Munoz-Hoyos A,. Effects of febrile and epileptic convulsions on daily variations in plasma melatonin concentration in children. J Pineal Res 1994; 16: 1-9.
25. Molina-Carballo A, Munoz-Hoyos A, Reiter RJ, et al. Utility of high doses of melatonin as adjunctive anticonvulsant therapy in a child with severe myoclonic epilepsy: two years experience. J Pineal Res 1997; 23: 97-105. (Pubitemid 127731744)
26. Niles LP, Pickering DS, Arciszewski MA,. Effects of chronic melatonin administration on GABA and diazepam binding in rat brain. J Neural Transm 1987; 2: 117-124.
27. Acuna-Castroviejo D, Lowenstein PR, Rosenstein R, Cardinali DP,. Diurnal variations of benzodiazepine binding in rat cerebral cortex: disruption by pinealectomy. J Pineal Res 1986; 3: 101-109. (Pubitemid 16017955)
28. Cardinali DP, Lowenstein PR, Rosenstein RE, et al. Functional links between benzodiazepine and GABA receptors and pineal activity. Adv Biochem Psychopharmacol 1986; 42: 155-164.
29. Morton DJ,. Effect of in vivo anticonvulsant drugs on pineal gland indol metabolism organ culture. Biochem Pharmacol 1986; 35: 1049-1050. (Pubitemid 16019873)
30. Hardeland R, Tan DX, Reiter RJ,. Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amines. J Pineal Res 2009; 47: 109-126.
31. Swartz KJ, During MJ, Freese A, Beal MF,. Cerebral synthesis and release of kynurenic acid: an endogenous antagonist of excitatory amino acid receptors. J Neurosci 1990; 10: 2965-2973.
32. Lapin IP, Prakhie IB, Kiseleva IP,. Antagonism of seizures induced by the administration of the endogenous convulsant quinolinic acid into rat brain ventricles. J Neural Transm 1986; 4: 177-185. (Pubitemid 16073141)
33. Thompson JL, Holmes GL, Taylor GW, Feldman DR,. Effects of kynurenic acid on amygdaloid kindling in the rat. Epilepsy Res 1988; 2: 302-308.
34. Singh L, Oles RJ, Tricklebank MD,. Modulation of seizure susceptibility in the mouse by the strychnine-insensitive glycine recognition site of the NMDA receptor/ion channel complex. Br J Pharmacol 1990; 99: 285-288. (Pubitemid 20147520)
35. Birch PJ, Grossman CJ, Hayes AG,. Kynurenate and FG9041 have both competitive and non-competitive antagonist actions at excitatory amino acid receptors. Eur J Pharmacol 1988; 151: 313-315.